http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2015520383-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-49 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-105 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-485 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6863 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6887 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
| filingDate | 2013-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2015-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2015520383-A |
| titleOfInvention | Method for diagnosing osteoarthritis |
| abstract | A method for managing osteoarthritis in a human or other mammalian subject, comprising platelet derived growth factor AB (PDGF-AB), platelet derived growth factor BB (PDGF-BB) in a tissue sample of the subject. And a measurement of specific cytokines and growth factors comprising one or more of epidermal growth factor (EGF). Tissue samples can be whole blood, blood fractions, urine, saliva, and synovial fluid. The method assesses the severity of osteoarthritis, such as in diagnosing osteoarthritis and in subjects diagnosed with osteoarthritis using x-ray or other methods Including a method for The method can also include comparing the measured cytokine level to a reference level. A method for managing the clinical progression of osteoarthritis includes initiating clinical action based on the difference between the measured cytokine level and the reference level. |
| priorityDate | 2012-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 313.